Skip to main content
  •   Home
  •   Download
  •   Manual
  •   Contact

Drug Details

General Information of the Drug (ID: DR8195)
Name
Selenite
Synonyms
selenite; Selenite ion; 14124-67-5; UNII-KXO0259XJ1; selenite(2-); KXO0259XJ1; Selenit; trioxoselenate(IV); trioxoselenate(2-); trioxidoselenate(2-); Selenium (IV) trioxide; Monohydrated selenuim dioxide; DTXSID9074517; SeO3(2-); CHEBI:18212; [SeO3](2-); C05684; Q27102911
    Click to Show/Hide
Molecular Type
Small molecule
Disease Arsenical melanosis [ICD-11: ED6Y] Phase 3 [1]
Structure
Click to Download Mol
2D MOL

3D MOL

    Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product
Formula
O3Se-2
PubChem CID
1090
Canonical SMILES
[O-][Se](=O)[O-]
InChI
1S/H2O3Se/c1-4(2)3/h(H2,1,2,3)/p-2
InChIKey
MCAHWIHFGHIESP-UHFFFAOYSA-L
CAS Number
CAS 14124-67-5
ChEBI ID
CHEBI:18212
DrugBank ID
DB11127
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally
    α. A List of Natural Product(s) Able to Enhance the Efficacy of This Drug
          Genistein      Glycine max     Click to Show/Hide the Molecular Data of This NP
                 Achieving Therapeutic Synergy     Click to Show/Hide
                    Representative Experiment Reporting the Effect of This Combination [2]
                    Detail(s)  Combination Info  click to show the detail info of this combination
                    Molecule(s)
                    Regulation
Down-regulation Expression AKT1  Molecule Info 
Pathway MAP
Up-regulation Expression BAX  Molecule Info 
Pathway MAP
Up-regulation Expression CDKN1A  Molecule Info 
Pathway MAP
                    In-vitro Model PC-3 CVCL_0035 Prostate carcinoma Homo sapiens
                    Experimental
                    Result(s)
Selenium and genistein act via different molecular mechanisms and exhibit enhanced anticancer effects.
Target and Pathway
Target(s) Thioredoxin reductase 1 (TXNRD1)  Molecule Info  [3]
Thioredoxin reductase 2 (TXNRD2)  Molecule Info  [3]
Thioredoxin reductase 3 (TXNRD3)  Molecule Info  [3]
References
Reference 1 ClinicalTrials.gov (NCT01442727) Selenium in the Treatment of Arsenic Toxicity and Cancers
Reference 2 Effects of selenite and genistein on G2/M cell cycle arrest and apoptosis in human prostate cancer cells. Nutr Cancer. 2009;61(3):397-407.
Reference 3 An alternative splicing variant of the selenoprotein thioredoxin reductase is a modulator of estrogen signaling. J Biol Chem. 2004 Sep 10;279(37):38721-9.
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
 Download Picture         KEGG Link      
Cite NPCDR
Visitor Map
Correspondence

X. N. Sun, Y. T. Zhang, Y. Zhou, X. C. Lian, L. L. Yan, T. Pan, T. Jin, H. Xie, Z. M. Liang, W. Q. Qiu, J. X. Wang, Z. R. Li, F. Zhu*, X. B. Sui*. NPCDR: natural product-based drug combination and its disease-specific molecular regulation. Nucleic Acids Research. 50(D1): 1324-1333 (2020). PMID: 34664659

Prof. Feng ZHU  (zhufeng@zju.edu.cn)

College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, China


Prof. Xinbing SUI  (hzzju@hznu.edu.cn)

School of Pharmacy and Department of Medical Oncology, the Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, China